Seattle Children's Hospital
Seattle Children's Hospital, founded in 1907, is a non-profit pediatric medical center and research institute located in Seattle, Washington. Recognized as one of the nation's best children's hospitals, it has consistently received accolades from U.S. News & World Report for over 25 years. The hospital provides comprehensive medical and surgical services to children and adolescents across Washington, Alaska, Montana, and Idaho. In addition to patient care, Seattle Children's is dedicated to pediatric research, aiming to develop innovative treatments and improve health outcomes for children. The hospital's operations and assets are managed by a board of trustees, ensuring effective governance and stewardship. Through its commitment to care and research, Seattle Children's strives to help every child achieve the healthiest and most fulfilling life possible.
GentiBio, Inc. is a biotherapeutics company focused on developing engineered regulatory T cells (EngTregs) to treat a range of conditions, including autoimmune, alloimmune, autoinflammatory, and allergic diseases. Founded in 2020 and based in Boston, Massachusetts, with additional locations in Seattle and Israel, GentiBio utilizes a proprietary platform that combines autologous and allogeneic EngTregs. This innovative approach aims to restore immune tolerance and address the limitations found in current regulatory T-cell therapies. The company was co-founded by experts in Treg biology and synthetic immunology, emphasizing its commitment to addressing the underlying causes of diseases linked to immune system dysfunction.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.